V-0219
V-0219 (Compound 9) is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R) . V-0219 can be used for obesity-associated diabetes research[1].
Product Specifications
CAS Number
[878453-71-5]
UNSPSC
12352005
Target
GLP Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/v-0219.html
Concentration
10mM
Purity
99.90
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC(C1=CC=C(C2=NOC(CN3CC(CN4CCOCC4)CCC3)=N2)C=C1)(F)F
Molecular Formula
C20H25F3N4O2
Molecular Weight
410.43
References & Citations
[1]Decara JM, et al. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "Diabesity". J Med Chem. 2022 Apr 14;65 (7) :5449-5461.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Prostaglandin E Synthase 2/PTGES2 Antibody (OTI2C3) [DyLight 350]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP2-73623UV 0.1 mL
Mouse Monoclonal Prostaglandin E Synthase 2/PTGES2 Antibody (OTI2C3) [DyLight 350]
Ask
View Details MBS6300465-01 0.2 mL
FXN, NT (FXN, FRDA, X25, Frataxin, mitochondrial, Friedreich ataxia protein, Frataxin intermediate form, Frataxin(56-210), m56-FXN, Frataxin(78-210), d-FXN, m78-FXN, Frataxin mature form, Frataxin(81-210), m81-FXN) (PE)
Ask
View Details 
MBS6300465-02 5x 0.2 mL
FXN, NT (FXN, FRDA, X25, Frataxin, mitochondrial, Friedreich ataxia protein, Frataxin intermediate form, Frataxin(56-210), m56-FXN, Frataxin(78-210), d-FXN, m78-FXN, Frataxin mature form, Frataxin(81-210), m81-FXN) (PE)
Ask
View Details